Triptans in the Italian population: a drug utilization study and a literature review

The Journal of Headache and Pain (Impact Factor: 3.28). 05/2008; 9(2):71-6. DOI: 10.1007/s10194-008-0020-3
Source: PubMed

ABSTRACT Previous studies performed in selected populations show a poor utilization of triptans for migraine. The objectives of our study were to establish patterns of triptans utilization in a large sample, covering 1/10 of Italian population (5.57 millions), and to perform a review of published studies on this topic. We investigated drug prescription database collected during 2006 from 33 health authorities distributed in 8 different regions. About 0.6% of the subjects received at least one prescription of triptans in 1 year: 77.7% were females and 22.3% males. Age distribution shows that 9.5% of patients were aged above 65, and received prescriptions for 8.2% of packages. The review of the literature suggests that these percentages of utilization are common to several countries, and shows that occasional triptan users who received only one prescription in 1 year are a large percentage (40-60%); moreover, a minor population of triptan users utilize a large amount of total triptans. Finally triptans are frequently prescribed in people aged above 65 years, a population in which triptans are contraindicated or not recommended. Our study and the analyzed ones indicate suboptimal treatment of migraine patients with triptans and also an incorrect use in some patients (triptan abusers, elderly).

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: . We continue our investigation of finite element approximations to the system of shallow water equations, based on the generalized wave continuity equation (GWCE) formulation. In previous work, we analyzed this system assuming Dirichlet boundary conditions on both elevation and velocity. Based on physical grounds, it is possible to not impose boundary conditions on elevation. Thus, we examine the formulation for the case of Dirichlet conditions on velocity only. The changes required to the finite element method are presented, and stability and error estimates are derived for both an approximate linear model and a full nonlinear model, assuming continous time. Stability for a discrete time method is also shown. Key words. boundary conditions, shallow water equations, wave shallow water equations, error estimates AMS subject classifications. 35Q35, 35L65 65N30, 65N15 1. Introduction. In this paper, we continue our investigation of finite element methods applied to the GWCE (Generaliz...
    SIAM Journal on Numerical Analysis 10/1998; DOI:10.1137/S0036142998341623
  • [Show abstract] [Hide abstract]
    ABSTRACT: Migraine is a complex neurological disorder in which genetic and environmental factors interact. At present, frontline therapies in migraine's acute treatment include the use of NSAIDS and triptans. Restrictions in the use of frontline drugs for migraine treatment and evidence concerning CGRP's key role led research towards new pathways involved in migraine pathophysiology. CGRP is a strong vasodilatory neuropeptide released from activated trigeminal sensory nerves. The development of CGRP antagonists has also been driven by the fact that triptans are vasoconstrictive and cannot be used in patients with vascular risk factors. BIBN4096 (olcegepant) is the first CGRP antagonist for the treatment of migraine which has been tested in clinical trials, but its principal limitation is that BIBN4096 presents low oral bioavailability and has only been tested through intravenous formulation. The first oral nonpeptide CGRP antagonist, MK-0974 (telcagepant), has recently been shown to be highly effective in the treatment of migraine attacks. This development can be considered the most important pharmacological breakthrough for migraine treatment since the introduction of sumatriptan in the early 1990s. These results are important since they confirm the current pathophysiological concept of migraine. The future introduction of CGRP antagonists in clinical practice could represent a progress for migraine therapy.
    Expert Review of Neurotherapeutics 10/2008; 8(9):1347-54. DOI:10.1586/14737175.8.9.1347
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The 5-hydroxytryptamine (5-HT) has been implicated in migraine pathophysiology for the past 50 years. A low central 5-HT disposition associated with an increase in 5-HT release during attack is the most convincing change of 5-HT metabolism implicated in migraine. Peripheral studies on plasma/platelet have not generally shown low 5-HT levels. Studies on 5-HT reactivity showed hypersensitivity, also expressed as reduced tachyphylaxis (habituation), which successively was evidenced as the most characteristic marker of an altered sensory neurotransmission. Even the gender and seasonal variations of 5-HT parameters seem to agree with a low 5-HT turnover with receptoral hypersensitivity. The interpretation of the effects of some serotonergic drugs and recent neuroimaging studies give major evidence for this cascade of events. Although the exact mechanism that links abnormal 5-HT neurotransmission to the manifestation of head pain has yet to be fully understood, a deficit on 5-HT descending pain inhibitory system is still probably today the most implicated in migraine pathophysiology. This short review focuses and discusses the alteration of peripheral and central 5-HT parameters in migraine patients.
    The Journal of Headache and Pain 11/2008; 9(5):267-76. DOI:10.1007/s10194-008-0058-2

Preview (2 Sources)

Available from